NCT02139592
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Osaka, Japan
Clinical trial condition
Lymphoma
Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.
3,652 public trials
850 recruiting studies
Lymphoma trial results
Completed
Study of Prognosis of Follicular Lymphoma Through a Prospective Collection of Data (F2-study)
NCT01250223
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Northwestern University Feinberg School of Medicine - Department of Hematology/Oncology Chicago, Illinois, United States
- University of Nebraska Medical Center Omaha, Nebraska, United States
- MD Anderson Cancer Center Houston, Texas, United States
- Academia Nacional de Medicina - Oncohematology Department, Instituto de Investigaciones Hematologicas Buenos Aires, Argentina
NCT03384043
- Conditions
- Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +20 more
- Locations
-
- Baylor Scott & White Medical Center Temple, Texas, United States
NCT00088205
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Woolloongabba, Queensland, Australia
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Parkville, Victoria, Australia
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Prahran, Victoria, Australia
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Wodonga, Victoria, Australia
Completed
Safety and Efficacy Study of PLX3397 in Adults With Relapsed or Refractory Hodgkin Lymphoma
NCT01217229
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
- Locations
-
- UCLA Jonsson Comprehensive Cancer Center Los Angeles, California, United States
- Northwestern University, The Robert H Lurie Comprehensive Cancer Center Chicago, Illinois, United States
- Mayo Clinic Rochester, Minnesota, United States
- Nebraska Medical Center Omaha, Nebraska, United States
NCT02055820
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
- St. Jude Heritage Healthcare Fullerton, California, United States
- UCLA Jonsson Comprehensive Cancer Center Los Angeles, California, United States
- Central Coast Medical Oncology Santa Maria, California, United States
- The West Clinici St Louis, Missouri, United States
NCT00939770
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +22 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Children's Hospital of Orange County Orange, California, United States
- UCSF Medical Center-Parnassus San Francisco, California, United States
NCT01742286
- Conditions
- ALK-activated Tumors, Granuloma, Granuloma, Plasma Cell, +26 more
- Locations
-
- Dana Farber Cancer Institute Dept of Onc Boston, Massachusetts, United States
- Memorial Sloan Kettering SC - 7 New York, United States
- Cincinnati Children s Hospital Medical Center Dept of Oncology Cincinnati, Ohio, United States
- St Jude s Childrens Research Hospital Dept of Oncology Memphis, Tennessee, United States
NCT01186978
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Durham Regional Hospital Durham, North Carolina, United States
- Duke University Medical Center Durham, North Carolina, United States
- Duke Raleigh Hospital Raleigh, North Carolina, United States
NCT03343652
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Lymphoma, +7 more
- Locations
-
- First Pavlov State Medical University of St. Petersburg Saint Petersburg, Russia